Browse > Article
http://dx.doi.org/10.14475/kjhpc.2014.17.2.57

The Effects of Plasma Endotoxin Level on Survival Time of Terminally Ill Cancer Patients  

Lee, Jin-Ah (Department of Family Medicine, Korea University College of Medicine)
Yoon, Ho Min (Department of Family Medicine, Korea University College of Medicine)
Choi, Youn Seon (Department of Family Medicine, Korea University College of Medicine)
Yeon, Jong Eun (Department of Internal Medicine, Korea University College of Medicine)
Lee, June Young (Department of Biostatistics, Korea University College of Medicine)
Publication Information
Journal of Hospice and Palliative Care / v.17, no.2, 2014 , pp. 57-65 More about this Journal
Abstract
Purpose: Since most terminally ill cancer patients die of multiple organ failure, plasma endotoxin concentration levels may be used to predict the life expectancy. This study was performed to evaluate the clinical significance of endotoxin level in plasma as a prognostic factor for survival in patients with terminal cancer. Methods: This study was conducted with 56 terminally ill cancer patients, above 20 years old, from April 2009 through October 2009. Demographic characteristics, Karnofsky performance status, and survival time were evaluated. We analyzed blood levels of white blood cell hemoglobin, hematocrit, aspartate aminotransferase, alanine aminotransferase, c-reactive protein, total bilirubin and endotoxin in each patient. Results: We considered following variable for univariate analysis: plasma endotoxin level, sex, age, WBC, hemoglobin, hematocrit, AST, ALT, total bilirubin, CRP and severity of pain. Univariate analysis did not show a significant association between plasma endotoxin level and survival time. However, in a multivariate analysis with factors that were found to be significantly associated with survival sex, WBC count and total bilirubin level in univariate analysis, high levels of plasma endotoxin and short survival time were significantly related. Conclusion: Plasma endotoxin level could be used as a prognostic factor to predict the life expectancy of terminally ill cancer patients.
Keywords
Endotoxins; Terminal care; Neoplasm; Prognosis; Hospice care;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Jung HH, Yoon H, Choi YS Choi, Lee JY, Yeon JE. The correlation of plasma endotoxin and components of systemic inflammatory response syndrome in terminally ill cancer patients. Korean J Clin Geri 2013;14:39-48.
2 Macarthur M, Hold GL, El-Omar EM. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol. 2004;286:G515-20.   DOI   ScienceOn
3 Lee KK, Yum KS. Association of endotoxins and colon polyp: a case-control study. J Korean Med Sci. 2012;27:1062-5.   DOI   ScienceOn
4 Chung JH, Kang MK, Rho JS, Yum KS. The association between visceral fat and endotoxin. Korean J Obes 2010;19:78-84.
5 Shin HS, Lee HR, Lee DC, Shim JY, Cho KH, Suh SY. Uric acid as a prognostic factor for survival time: a prospective cohort study of terminally ill cancer patients. J Pain Symptom Manage 2006;31:493-501.   DOI   ScienceOn
6 Astrakianakis G, Seixas N, Camp J, Smith TJ, Bartlett K, Checkoway H. Cotton dust and endotoxin levels in three Shanghai textile factories: a comparison of samplers. J Occup Environ Hyg. 2006;3:418-27.   DOI   ScienceOn
7 Werling D, Jungi TW. TOLL-like receptors linking innate and adaptive immune response. Vet Immunol Immunopathol 2003;91: 1-12.   DOI   ScienceOn
8 Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice:mutations in Tlr4 gene. Science 1998;282:2085-8.   DOI   ScienceOn
9 Hong S, Qian J, Yang J, Li H, Kwak LW, Yi Q. Roles of idiotype-specific t cells in myeloma cell growth and survival: Th1 and CTL cells are tumoricidal while Th2 cells promote tumor growth. Cancer Res 2008;68:8456-64.   DOI   ScienceOn
10 Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Konigsrainer A, et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 2008;138:1452-5.   DOI
11 Luster MI, Germolec DR, Yoshida T, Kayama F, Thompson M. Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology 1994;19:480-8.   DOI   ScienceOn
12 Hartung T, Wendel A. Endotoxin-inducible cytotoxicity in liver cell cultures-I. Biochem Pharmacol 1991;42:1129-35.   DOI   ScienceOn
13 Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999;340:207-14.   DOI   ScienceOn
14 Wig JD, Kochhar R, Ray JD, Krishna Rao DV, Gupta NM, Ganguly NK. Endotoxemia predicts outcome in acute pancreatitis. J Clin Gastroenterol 1998;26:121-4.   DOI   ScienceOn
15 Buttenschoen K, Kornmann M, Berger D, Leder G, Beger HG, Vasilescu C. Endotoxemia and endotoxin tolerance in patients with ARDS. Langenbecks Arch Surg 2008; 393:473-8.   DOI   ScienceOn
16 Berger D, Schmidt UM, Ott S, Seidelmann M, Martin R, Beger HG. Incidence and pathophysiological relevance of postoperative endotoxemia. FEMS Immunol Med Microbiol 1995;11:285-90.   DOI   ScienceOn
17 Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time? Crit Care Med 1998;26:2078-86.   DOI   ScienceOn
18 Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parillo JE. Endotoxemia in human septic shock. 1991. Chest 1991;99: 169-75.   DOI   ScienceOn
19 Lundin JI, Checkoway H. Endotoxin and cancer. Environ Health Perspect 2009;117:1344-50.   DOI   ScienceOn
20 Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, Reding D, et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 1998;279: 1709-14.   DOI   ScienceOn
21 Suh SY. Survival prediction of terminally iIll cancer patients. Korean J Hosp Palliat Care 2007;10:171-7.
22 Rosenthal MA, Gebski VJ, Kefford RF, Stuart-Harris RC. Prediction of life-expectancy in hospice patients: identification of novel prognostic factors. Palliat Med 1993;7:199-204.   DOI   ScienceOn
23 Geissbuhler P, Mermillod B, Rapin CH. Elevated serum vitamin B12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: a prospective study over five years. J Pain Symptom Manage 2000;20:93-103.   DOI   ScienceOn
24 Pirovano M, Maltoni M, Nanni O, Marinari M, Indelli M, Zaninetta G, et al. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage 1999;17:231-9.   DOI   ScienceOn
25 Maltoni M, Pirovano M, Nanni O, Marinari M, Indelli M, Gramazio A, et al. Biological indices predictive of survival in 519 Italian terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage 1997;13:1-9.   DOI   ScienceOn
26 Suh SY, Ahn HY. Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study. Eur J cancer 2007;43:1051-9.   DOI   ScienceOn
27 Korea National Statistical Office. 2007 statistical result of death and cause of death [internet]. Daejeon: Statistics Korea; 2008. [cited 2010 May 7]. Available from: http://www.index.go.kr.
28 Christakis NA, Lamont EB. Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort study. BMJ 2000;320:469-72.   DOI   ScienceOn
29 Lamont EB, Christakis NA. Some elements of prognosis in terminal cancer. Oncology (Williston Park) 1999;13:1165-70;discussion 1172-4, 1179-80.
30 Lamont EM, Siegler M. Paradoxes in cancer patients’ advance care planning. J Palliat Med 2000;3:27-35.   DOI   ScienceOn
31 Steensma DP, Loprinzi CL. The art and science of prognosis in patients with advanced cancer. Eur J Cancer 2000;36:2025-7.   DOI   ScienceOn
32 Viganò A, Dorgan M, Bruera E, Suarez-Almazor ME. The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. Cancer 1999;86:170-6.   DOI
33 Lamont EB, Christakis NA. Physician factors in the timing of cancer patient referral to hospice palliative care. Cancer 2002;94: 2733-7.   DOI   ScienceOn
34 Sunil VR, Patel KJ, Nilsen-Hamilton M, Heck DE, Laskin JD, Laskin DL. Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver. Exp Mol Pathol 2007; 83:177-87.   DOI   ScienceOn
35 Schmidt C. Immune system's Toll-like receptors have good opportunity for cancer treatment. J Natl Cancer Inst 2006;98: 574-5.   DOI   ScienceOn
36 McMillan DC, Elahi MM, Sattar N, Angerson WJ, Johnstone J, McCardle CS. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 2001;41:64-9.   DOI
37 Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003;3:169-76.   DOI   ScienceOn